SCHEMBL2268996

SCHEMBL2268996

NC(=O)c1n[nH]cc1NCCCc1cccc(N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 2/20 0.39
AURKA O14965 1/20 0.39
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
KDM4E B2RXH2 2/20 0.37
ASPH Q12797 2/20 0.37
RIOX2 Q8IUF8 2/20 0.37
KDM8 Q8N371 2/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
GSK3A P49840 2/20 0.36
GSK3B P49841 2/20 0.36
KDM6B O15054 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
HDAC6 Q9UBN7 2/20 0.36
GLS O94925 1/20 0.35
CYP19A1 P11511 1/20 0.35
ROCK2 O75116 1/20 0.35
PARP1 P09874 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264927 0.93 RPS6KB1 (0.40) RPS6KB1AURKAKDM4EASPHRIOX2
SCHEMBL2264874 0.87 RPS6KB1 (0.50) RPS6KB1AURKAGSK3BROCK2PARP1
SCHEMBL2264166 0.84 KMT2A (0.49) KDM4EHDAC6
SCHEMBL2269001 0.76 ADRB2 (0.41) RPS6KB1AURKAROCK2PARP1
SCHEMBL2264918 0.69 HSD11B1 (0.40) RPS6KB1AURKAROCK2PARP1
SCHEMBL951922 0.69 MAOA (0.53) MTNR1AMTNR1BKDM4EMAOAMAOB
SCHEMBL15272646 0.68 MAOA (0.55) MAOAMAOBHDAC6GLSCYP19A1
SCHEMBL3818291 0.68 PARP1 (0.52) RPS6KB1AURKAPARP1
SCHEMBL2268989 0.67 HSD11B1 (0.37) RPS6KB1AURKAROCK2PARP1
SCHEMBL3134457 0.67 POLB (0.49) MTNR1AMTNR1BMAOAMAOBCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420824-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI (FR) 2013-04-16 US disclosed
US-8410286-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2013-04-02 US disclosed
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2011-09-29 US disclosed
US-7989439-B2 Substituted pyrazoles, compositions containing these, method of production and use SANOFI-AVENTIS (FR) 2011-08-02 US disclosed
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE SANOFI-AVENTIS (FR) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237801-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 RPS6KB1 422/4885AURKA 693/4885MTNR1A 1196/4885
US-20090291984-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE CYP4B1, ADORA1, CYP1B1 RPS6KB1 310/4885AURKA 719/4885MTNR1A 1015/4885
US-20110237641-A1 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE ADORA3, ADORA2B, CYP4B1 RPS6KB1 422/4885AURKA 693/4885MTNR1A 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.